RP Bio lnc (XKRX:314140) Interest Expense : ₩-1,746 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. RP Bio lnc's interest expense for the three months ended in Mar. 2024 was ₩ -342 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,746 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. RP Bio lnc's Operating Income for the three months ended in Mar. 2024 was ₩ -262 Mil. RP Bio lnc's Interest Expense for the three months ended in Mar. 2024 was ₩ -342 Mil. RP Bio lnc did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

RP Bio lnc Interest Expense Historical Data

The historical data trend for RP Bio lnc's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Interest Expense Chart

RP Bio lnc Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Interest Expense

-594.64

-1,123.19

-979.22

-1,183.75

RP Bio lnc Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial						-391.00	-402.09	-436.81	-565.61	-341.85

RP Bio lnc Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,746 Mil.

RP Bio lnc (XKRX:314140) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

RP Bio lnc's Interest Expense for the three months ended in Mar. 2024 was ₩-342 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-262 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩4,616 Mil.

RP Bio lnc's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

RP Bio lnc did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

RP Bio lnc (XKRX:314140) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084

Website

http://www.rpskorea.com

RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines